Physician Dispensed Cosmeceuticals - Global Market Trajectory & Analytics

Global Physician Dispensed Cosmeceuticals Market to Reach US$28.3 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Physician Dispensed Cosmeceuticals estimated at US$15.7 Billion in the year 2020, is projected to reach a revised size of US$28.3 Billion by 2027, growing at a CAGR of 8.7% over the analysis period 2020-2027. Skin Care, one of the segments analyzed in the report, is projected to grow at a 9.9% CAGR to reach US$12.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hair Care segment is readjusted to a revised 8.3% CAGR for the next 7-year period. This segment currently accounts for a 23.2% share of the global Physician Dispensed Cosmeceuticals market.

The U.S. Accounts for Over 37.6% of Global Market Size in 2020, While China is Forecast to Grow at a 10.9% CAGR for the Period of 2020-2027

The Physician Dispensed Cosmeceuticals market in the U.S. is estimated at US$5.9 Billion in the year 2020. The country currently accounts for a 37.63% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$2.2 Billion in the year 2027 trailing a CAGR of 10.9% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 7.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8% CAGR while Rest of European market (as defined in the study) will reach US$2.2 Billion by the year 2027.

Eye Care Segment Corners a 18% Share in 2020

In the global Eye Care segment, USA, Canada, Japan, China and Europe will drive the 7.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.2 Billion in the year 2020 will reach a projected size of US$3.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.9 Billion by the year 2027, while Latin America will expand at a 8.8% CAGR through the analysis period.

Select Competitors (Total 120 Featured) -

• Allergan Plc
• SkinMedica, Inc.
• Biopelle, Inc.
• Clinique Laboratories, LLC
• Cutera, Inc.
• Emerson Ecologics, LLC
• iS CLINICAL
• Jan Marini Skin Research, Inc.
• La Roche-Posay Laboratoire Pharmaceutique
• Neutrogena Corp.
• Obagi Medical Products, Inc.
• SkinCeuticals
• Stiefel Laboratories, Inc.

What's New for 2022?

• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to the publisher's digital archives and Research Platform
• Complimentary updates for one year